<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Polymorphic paraoxonase (PON1) variants can variably prevent low- and <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> oxidation, but their role in provoking <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> remained unclear </plain></SENT>
<SENT sid="1" pm="."><plain>We addressed this issue by profiling PON1 polymorphisms and enzymatic activities, and assessing <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and cerebral <z:hpo ids='HP_0002634'>arteriosclerosis</z:hpo> severity in post-<z:hpo ids='HP_0001297'>stroke</z:hpo> patients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Carotid artery intima-media-thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>), cerebral white matter lesions (WML), serum PON1 -108C/T, Q192R and L55M polymorphisms, and PON and acetylcholinesterase (AChE) enzyme activities were determined in 237 patients </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Genetic variation at the PON1 locus showed a strong influence on PON1 activity in ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> patients, but lacked direct influence on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> patients with PON1 QQ192 or MM55 genotypes demonstrated lower PON and arylesterase activities at both Day 1 and 12 months post-<z:hpo ids='HP_0001297'>stroke</z:hpo> than patients with either RQ/RR192 or LM/LL55 genotypes (P &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, patients with carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and/or cerebral <z:hpo ids='HP_0002634'>arteriosclerosis</z:hpo> expressed as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, carotid plaques and WML had lower 12 months PON1 activity than patients without (P = 0.02, P = 0.027 and P = 0.001, respectively), and PON and AChE hydrolysis rates were more tightly correlated in patients carrying the PON1 192R compared with the 192QQ allele, in a gene dose-dependent manner (P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Our findings show inverse PON1 activity-carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and -cerebral <z:hpo ids='HP_0002634'>arteriosclerosis</z:hpo> association in <z:hpo ids='HP_0001297'>stroke</z:hpo> patients: the lower the PON1 activity the more progressed is the atherosclerotic process and the weaker is the association with AChE activity </plain></SENT>
<SENT sid="7" pm="."><plain>Extending previous PON1 genetic studies in <z:hpo ids='HP_0001297'>stroke</z:hpo> populations, our study emphasizes the PON1 activity as a potential anti-atherogenic element and proposes involvement of cholinesterase activities in its effects </plain></SENT>
</text></document>